Overview

A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis

Status:
Terminated

Trial end date:
2011-09-01

Target enrollment:

Participant gender:

Summary

This study is designed to evaluate the safety and efficacy of an oral medicine (called apremilast) for treating skin involvement in patients with the disease dermatomyositis.

Phase:

N/A

Details

Lead Sponsor:

Stanford University

Treatments:

Apremilast
Thalidomide